Company Filing History:
3 out of 9 
3 out of 3,540 
1 out of 832,912 Years Active: 2005-2012
Title: The Innovations of Richard Allan Slayden
Introduction
Richard Allan Slayden is a notable inventor based in Ft. Collins, Colorado. He has made significant contributions to the field of infectious disease treatment, particularly focusing on tuberculosis. With a total of four patents to his name, Slayden's work has the potential to impact public health positively.
Latest Patents
Slayden's latest patents include compositions and methods for the treatment of infectious diseases. These methods specifically target diseases caused by infectious agents, with a strong emphasis on tuberculosis. His innovative approaches involve the use of substituted ethylene diamines for treating mycobacterial infections, including tuberculosis. Another significant patent focuses on anti-tubercular drugs, further enhancing the treatment options available for this serious health issue.
Career Highlights
Throughout his career, Slayden has worked with prominent organizations such as Sequella, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to develop and refine his innovative ideas in the realm of infectious disease treatment.
Collaborations
Some of Slayden's notable coworkers include Marina Nikolaevna Protopopova and Richard Edward Lee. Their collaborative efforts have contributed to the advancement of research and development in the field of infectious diseases.
Conclusion
Richard Allan Slayden's contributions to the treatment of infectious diseases, particularly tuberculosis, highlight his role as an influential inventor. His innovative patents and collaborations with esteemed organizations underscore the importance of his work in improving public health outcomes.